Incannex full steam ahead towards sleep apnoea trial

Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) chief medical officer Dr Mark Bleakley speaks with Proactive after the company received clearance from the US...

Related Keywords

Mark Bleakley ,Incannex Healthcare Ltd ,Nasdaq ,Drug Administration ,Investigational New Drug ,